ALK Positive helped fund researchers at @BIDMChealth @DanaFarber & more to help immune cells attack cancer. Early results are in lymphoma; the approach is now being explored in #lungcancer.
@alkpositive.bsky.social
@alkpositive.bsky.socialALK Positive helped fund researchers at @BIDMChealth @DanaFarber & more to help immune cells attack cancer. Early results are in lymphoma; the approach is now being explored in #lungcancer.
@lungcancereurope.bsky.socialGood news for #lungcancer screening in Europe.
Poland is launching a nationally funded lung cancer screening programme this Oct, offering free low-dose CT scans to people at higher risk.
Access to early detection still varies widely across Europe. This is an important step forward. #LCSM
@allyouneedislungs.bsky.socialHow can we spot #lungcancer earlier in people who have never smoked?
A new review found 31 existing prediction models, but none met all quality standards.
More research is needed to help identify who may be at risk.
@oncogenecancer.bsky.socialWhat does progress in #lungcancer mean for everyday life? Why do patient voices matter in research?
Our Chair &
@alkpositive.bsky.social
BoD
@yvonnediaz.bsky.social
&
@dryolaolo.bsky.social
discuss all in a takeover of
@iaslc.bsky.social ’s Lung Cancer Considered podcast
🎧 bit.ly/3TA4gv3
@vcclibrary.bsky.socialLazertinib Plus Pemetrexed and Carboplatin in Patients With EGFR-Mutant Advanced Non-Small Cell #LungCancer after Progression on Lazertinib. www.ejcancer.com/article/S095...
@lungcancereurope.bsky.socialAround 1,700 #lungcancer cases could be prevented across the EU over the next 40 years under stronger workplace protections, according to the European Commission.
The European Parliament backed the new rules this week.
@allyouneedislungs.bsky.socialWhy do people who have never smoked develop #lungcancer?
The UK’s OLIVE study is looking at who is affected, how lung cancer is diagnosed and outcomes, with the aim of improving diagnosis and care. #LCSM
@jamainternalmed.comAmong patients due for annual #LungCancer screening, stepped reminders to primary care physicians to order and patients to schedule low-dose computed tomography increased guideline-concordant screening adherence vs usual care. ja.ma/4zcBboo
@vcclibrary.bsky.socialSmoking Cessation Among Underserved Patients Referred for #LungCancer Screening: A Randomized Clinical Trial. jamanetwork.com/journals/jam...
@tamedoncol.bsky.socialGet ready for #ESMO26 by revisiting the evolving treatment landscape of #SCLC with this review published on #TAMO in 2025.
From current standards to DLL3-targeted therapies, #ADCs and emerging biomarkers.
#Lungcancer
🔗 buff.ly/B2U9VpQ
@Roya_Behrouzi @fblackhall
@go2forlungcancer.bsky.socialThere are many ways to #ShineALight on #LungCancer.
Host an in-person or virtual event, or create an educational display to bring your community together during #LungCancerAwarenessMonth this November. 🫁
Learn more and register. 👉 hcp.go2.org/shine-a-light/
@lungcancereurope.bsky.social🆕 research looks at what may happen before some smoking-related lung cancers develop.
Long-term cigarette smoke exposure changed lung stem cells in a lab model, with KRAS linked to adenocarcinoma and TP53 loss to squamous cell carcinoma. #LCSM #lungcancer
@genesndiseases.bsky.socialWhy do some #LungCancer patients fail to benefit from PD-1/PD-L1 #immunotherapy?
This study identifies ANP32A as a regulator of #PDL1, showing that its loss enhances EP300/CREBBP activity and may influence treatment response.
#OpenAccess #GenesAndDiseases: doi.org/10.1016/j.ge...
@lungcancereurope.bsky.social#Lungcancer screening is also a chance to offer help with 🚭 .
A US trial of 3.2K people referred for screening, 8.8% offered medication & financial incentives had verified abstinence at 6 mths, Vs 4.3% given usual support.
Practical help, without judgement.
@lcrf.orgLCRF's e-news is out! If it's not in your inbox, you can still catch up on science updates, upcoming events, and more – LCRF.org/enews
@fumikochino.bsky.social💸🏥🩺 Medical debt is a scourge. In addition to the deep personal and economic harms it perpetuates on Americans, new data @jamanetworkopen.com @jama.com shows that it may ALSO drive incidence of late-stage cancer diagnoses with the worst outcomes in #lungcancer #lcsm
@go2forlungcancer.bsky.socialYou are not alone. 🩵
Join our Gathering HOPE virtual group to connect with others impacted by #LungCancer, share experiences, and find support.
🗓️ October 13
🕔 11 a.m. PT | 2 p.m. ET
🔗 Register today: go2.org/resources-an...
@eaonc.bsky.socialThe EA5221/ACHIEVE clinical study is testing two different treatment approaches for older adults with advanced non-small cell #LungCancer. Learn more: https://bit.ly/ea5221-achieve #NSCLC #LCSM
@lungcancereurope.bsky.socialIt’s the FINAL week for our 12th Annual Report Survey.
We’re gathering evidence on quality of life and support needs for people affected by #lungcancer across Europe.
Please take part if eligible, or share with patients, members and networks:
es.surveymonkey.com/r/LungCancer... #LCSM
@pemf-devices.bsky.socialHydrogen inhalation for smokers offers a breakthrough approach to healing smoke-damaged lungs. Read this research review article to learn more: pemf-devices.com/hydrogen-inh...
#smokingcessation #hydrogeninhalation #molecularhydrogen #lunghealth #smokingharmreduction #lungcancer
